Literature DB >> 30199652

The Injurious Effects of Elevated or Nonelevated Respiratory Rate during Mechanical Ventilation.

Evangelia Akoumianaki1, Katerina Vaporidi1, Dimitris Georgopoulos1.   

Abstract

Respiratory rate is one of the key variables that is set and monitored during mechanical ventilation. As part of increasing efforts to optimize mechanical ventilation, it is prudent to expand understanding of the potential harmful effects of not only volume and pressures but also respiratory rate. The mechanisms by which respiratory rate may become injurious during mechanical ventilation can be distinguished in two broad categories. In the first, well-recognized category, concerning both controlled and assisted ventilation, the respiratory rate per se may promote ventilator-induced lung injury, dynamic hyperinflation, ineffective efforts, and respiratory alkalosis. It may also be misinterpreted as distress delaying the weaning process. In the second category, which concerns only assisted ventilation, the respiratory rate may induce injury in a less apparent way by remaining relatively quiescent while being challenged by chemical feedback. By responding minimally to chemical feedback, respiratory rate leaves the control of V. e almost exclusively to inspiratory effort. In such cases, when assist is high, weak inspiratory efforts promote ineffective triggering, periodic breathing, and diaphragmatic atrophy. Conversely, when assist is low, diaphragmatic efforts are intense and increase the risk for respiratory distress, asynchronies, ventilator-induced lung injury, diaphragmatic injury, and cardiovascular complications. This review thoroughly presents the multiple mechanisms by which respiratory rate may induce injury during mechanical ventilation, drawing the attention of critical care physicians to the potential injurious effects of respiratory rate insensitivity to chemical feedback during assisted ventilation.

Entities:  

Keywords:  control of breathing; diaphragmatic dysfunction; patient–ventilator interaction; respiratory rate; ventilator-induced lung injury

Mesh:

Year:  2019        PMID: 30199652     DOI: 10.1164/rccm.201804-0726CI

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  ELMO helmet for CPAP to treat COVID-19-related acute hypoxemic respiratory failure outside the ICU: aspects of/comments on its assembly and methodologyAuthors' replyPatient self-inflicted lung injury and positive end-expiratory pressure for safe spontaneous breathingELMO 1 0: a helmet interface for CPAP and high-flow oxygen deliveryProtecting healthcare workers from SARS-CoV-2 infection practical indications.

Authors:  Mariano Mazza; Giuseppe Fiorentino; Antonio M Esquinas
Journal:  J Bras Pneumol       Date:  2022-05-13       Impact factor: 2.800

Review 2.  Respiratory system as the main determinant of dyspnea in patients with pulmonary hypertension.

Authors:  Ioanna Mitrouska; Maria Bolaki; Katerina Vaporidi; Dimitris Georgopoulos
Journal:  Pulm Circ       Date:  2022-03-23       Impact factor: 2.886

3.  Ventilatory frequency during intraoperative mechanical ventilation and postoperative pulmonary complications: a hospital registry study.

Authors:  Peter Santer; Shengxing Zheng; Maximilian Hammer; Sarah Nabel; Ameeka Pannu; Yunping Li; Satya Krishna Ramachandran; Marcos F Vidal Melo; Matthias Eikermann
Journal:  Br J Anaesth       Date:  2020-03-26       Impact factor: 9.166

4.  Titration and characteristics of pressure-support ventilation use in Argentina: an online cross-sectional survey study.

Authors:  Joaquin Pérez; Javier Hernán Dorado; Ana Carolina Papazian; Maricel Berastegui; Daniela Inés Gilgado; Gimena Paola Cardoso; Cristian Cesio; Matías Accoce
Journal:  Rev Bras Ter Intensiva       Date:  2020-05-08

5.  Flow Index accurately identifies breaths with low or high inspiratory effort during pressure support ventilation.

Authors:  Filippo Albani; Federica Fusina; Gianni Ciabatti; Luigi Pisani; Valeria Lippolis; Maria Elena Franceschetti; Alessia Giovannini; Rossella di Mussi; Francesco Murgolo; Antonio Rosano; Salvatore Grasso; Giuseppe Natalini
Journal:  Crit Care       Date:  2021-12-15       Impact factor: 9.097

6.  Examining lung mechanical strains as influenced by breathing volumes and rates using experimental digital image correlation.

Authors:  C A Mariano; S Sattari; K A M Quiros; T M Nelson; M Eskandari
Journal:  Respir Res       Date:  2022-04-11

7.  Lung- and Diaphragm-Protective Ventilation.

Authors:  Ewan C Goligher; Martin Dres; Bhakti K Patel; Sarina K Sahetya; Jeremy R Beitler; Irene Telias; Takeshi Yoshida; Katerina Vaporidi; Domenico Luca Grieco; Tom Schepens; Giacomo Grasselli; Savino Spadaro; Jose Dianti; Marcelo Amato; Giacomo Bellani; Alexandre Demoule; Eddy Fan; Niall D Ferguson; Dimitrios Georgopoulos; Claude Guérin; Robinder G Khemani; Franco Laghi; Alain Mercat; Francesco Mojoli; Coen A C Ottenheijm; Samir Jaber; Leo Heunks; Jordi Mancebo; Tommaso Mauri; Antonio Pesenti; Laurent Brochard
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 30.528

Review 8.  Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.

Authors:  Domenico Luca Grieco; Salvatore Maurizio Maggiore; Oriol Roca; Elena Spinelli; Bhakti K Patel; Arnaud W Thille; Carmen Sílvia V Barbas; Marina Garcia de Acilu; Salvatore Lucio Cutuli; Filippo Bongiovanni; Marcelo Amato; Jean-Pierre Frat; Tommaso Mauri; John P Kress; Jordi Mancebo; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2021-07-07       Impact factor: 17.440

Review 9.  Clinical strategies for implementing lung and diaphragm-protective ventilation: avoiding insufficient and excessive effort.

Authors:  Ewan C Goligher; Annemijn H Jonkman; Jose Dianti; Katerina Vaporidi; Jeremy R Beitler; Bhakti K Patel; Takeshi Yoshida; Samir Jaber; Martin Dres; Tommaso Mauri; Giacomo Bellani; Alexandre Demoule; Laurent Brochard; Leo Heunks
Journal:  Intensive Care Med       Date:  2020-11-02       Impact factor: 41.787

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.